SAN FRANCISCO, CA---Can treatments that reduce risks for cardiovascular disease (CVD) also help combat age-related macular degeneration (AMD), an eye disease that affects millions of Americans? CVD ...

"Identifying an association between AMD and valvular heart disease may provide important insights to the pathogenesis of AMD, may serve as a biomarker for these diseases, and may potentially assist in ...

Baseline AMD severity and fellow-eye status were highly predictive of progression to AAMD. Family history was also predictive, especially for participants with two or more affected family members. The ...

2006 Joint Meeting of the American Academy of Ophthalmology and Asia Pacific Academy of Ophthalmology Coverage from AAO 2006 includes the highlights in retinal disease, glaucoma, neuro-ophthalmology, ...

A new study shows that in patients with intermediate nonneovascular age-related macular degeneration, levodopa treatment is ...

The subretinal drusenoid deposit form of age-related macular degeneration (AMD) was found to be associated with valvular heart disease as well as cardiac index. The subretinal drusenoid deposit (SDD) ...

An international collaboration of scientists publishing in Nature Reviews Disease Primers this week advocate for a new way of thinking about and finding treatments for age-related macular degeneration ...

Please provide your email address to receive an email when new articles are posted on . During the COVID slowdown, researchers seem to have sped up publishing breakthrough research on age-related ...

Treatments are available for dry AMD patients who also have geographic atrophy, but until the FDA's recent authorization of light therapy, those with dry AMD alone had no treatment options other than ...

Multimodal imaging, including OCT and FAF, is crucial for differentiating between AMD and IRDs, enabling precise diagnosis.